Meclizine
Meclizine Hydrochloride is a prescription medication used to treat nausea, vomiting, and dizziness caused by motion sickness or vertigo. It comes as oral tablets in strengths of 12.5 mg, 25 mg, and 50 mg, manufactured by Aurobindo Pharma Limited. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[ "009:10" ] |
| contactPoint |
{ "fn": "Division of Drug Information", "@type": "vcard:Contact", "hasEmail": "mailto:druginfo@fda.hhs.gov" } |
| description | Meclizine Hydrochloride is a prescription medication used to treat nausea, vomiting, and dizziness caused by motion sickness or vertigo. It comes as oral tablets in strengths of 12.5 mg, 25 mg, and 50 mg, manufactured by Aurobindo Pharma Limited. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[ { "@type": "dcat:Distribution", "title": "Meclizine", "mediaType": "text/html", "description": " Access the FDA dataset for Meclizine — ANDA 010721 submitted by Mylan Institutional LLC ", "downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=010721" } ] |
| identifier | ANDA010721 |
| issued | 2016-09-16 |
| keyword |
[ "drug", "drug-information", "medications", "prescription-drugs", "public-health" ] |
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[ "009:002" ] |
| publisher |
{ "name": "U.S. Food and Drug Administration", "@type": "org:Organization" } |
| theme |
[ "FDA" ] |
| title | Meclizine |
